CoChat

hi PSC‐derived iMSC s: NextGen MSC s as an advanced therapeutically active cell resource for regenerative medicine

Open access
Sabapathy, Vikram, Kumar, Sanjay · 2016 · Journal of Cellular and Molecular Medicine
Cited by 123

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Mesenchymal stem cells (MSC s) are being assessed for ameliorating the severity of graft‐versus‐host disease, autoimmune conditions, musculoskeletal injuries and cardiovascular diseases. While most of these clinical therapeutic applications require substantial cell quantities, the number of MSC s that can be obtained initially from a single donor remains limited. The utility of MSC s derived from human‐induced pluripotent stem cells (hi PSC s) has been shown in recent pre‐clinical studies. Since adult MSC s have limited capability regarding proliferation, the quantum of bioactive factor secretion and immunomodulation ability may be constrained. Hence, the alternate source of MSC s is being considered to replace the commonly used adult tissue‐derived MSC s. The MSC s have been obtained from various adult and foetal tissues. The hi PSC‐derived MSC s (iMSC s) are transpiring as an attractive source of MSC s because during reprogramming process, cells undergo rejuvination, exhibiting better cellular vitality such as survival, proliferation and differentiations potentials. The autologous iMSC s could be considered as an inexhaustible source of MSC s that could be used to meet the unmet clinical needs. Human‐induced PSC‐derived MSC s are reported to be superior when compared to the adult MSC s regarding cell proliferation, immunomodulation, cytokines profiles, microenvironment modulating exosomes and bioactive paracrine factors secretion. Strategies such as derivation and propagation of iMSC s in chemically defined culture conditions and use of footprint‐free safer reprogramming strategies have contributed towards the development of clinically relevant cell types. In this review, the role of i PSC‐derived mesenchymal stromal cells (iMSC s) as an alternate source of therapeutically active MSC s has been described. Additionally, we also describe the role of iMSC s in regenerative medical applications, the necessary strategies, and the regulatory policies that have to be enforced to render iMSC's effectiveness in translational medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jcmm.12839

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 123

Metadata

Authors
Sabapathy, V., & Kumar, S.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2016-04-21
Volume
20
Issue
8
Pages
1571-1588
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2338920735
Cited by
123
References
35
FWCI
5.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.